Gemcitabine Hydrochloride is a nucleoside analog used as chemotherapy. It is marketed as Gemzar® by Eli Lilly and Company. Gemcitabine is used in various carcinomas: non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. Reference standards of Gemcitabine Hydrochloride API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Gemcitabine Hydrochloride - API Standards [catalogue_number] => PA 07 05000 [category_ids] => ,78,70,82,85,83, [chemical_name] => [weight] => 299.66 [form] => C9H12ClF2N3O4 [cas] => 122111-03-9 [pslug] => 122111-03-9-gemcitabine-hydrochloride-api-pa0705000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 36618 [offers_product_code] => PA 07 05000 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 07 05000
CAS :
Molecular Formula : C9H12ClF2N3O4
Molecular Weight : 299.66
stdClass Object ( [pname] => Gemcitabine Hydrochloride - Impurity B [catalogue_number] => PA 07 05020 [category_ids] => 76,75,70,78,82,83,85 [chemical_name] => [weight] => 263.20 [form] => C9H11F2N3O4 [cas] => 95058-85-8 [pslug] => 95058-85-8-gemcitabine-hydrochloride-impurity-b-pa0705020 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 36621 [offers_product_code] => PA 07 05020 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 07 05020
Molecular Formula : C9H11F2N3O4
Molecular Weight : 263.20
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
